Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

https://clinicaltrials.gov/study/NCT06939166?cond=Multiple+Sclerosis

Smart Monitoring Assessing Spasticity-related Health

https://clinicaltrials.gov/study/NCT06937723?cond=Multiple+Sclerosis

Promotion of Exercise Through Physical Therapy for Multiple Sclerosis: A Pilot Study

https://clinicaltrials.gov/study/NCT06933160?cond=Multiple+Sclerosis

A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-509372-41-00

Effects of Mat and Reformer Pilates in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06931522?cond=Multiple+Sclerosis

Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06930339?cond=Multiple+Sclerosis

Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.

https://clinicaltrials.gov/study/NCT06928194?cond=Multiple+Sclerosis

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)

https://clinicaltrials.gov/study/NCT06925022?cond=Multiple+Sclerosis

Weight-loss lifestyle changes slow bone loss in older adults https://www.diningandcooking.com/2015899/weight-loss-lifestyle-changes-slow-bone-loss-in-older-adults/ #aging #Bone #BoneHealth #BoneMineralDensity #ClinicalTrial #diet #exercise #Healthcare #Mediterranean #MediterraneanDiet #MetabolicSyndrome #obesity #osteoporosis #PhysicalActivity #spine #Syndrome #WeightLoss

MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience

https://clinicaltrials.gov/study/NCT06922942?cond=Multiple+Sclerosis

Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06921551?cond=Multiple+Sclerosis

Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT)

https://clinicaltrials.gov/study/NCT06920524?cond=Multiple+Sclerosis

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06919900?cond=Multiple+Sclerosis

Effects of Sailing and Cooing in the Quality of Life of Multiple Sclerosis Individuals

https://clinicaltrials.gov/study/NCT06915272?cond=Multiple+Sclerosis

#AI and #healthcare researchers

The first talks from the Italian Association of Medical Statistics and Clinical Epidemiology (#Sismec) Working Group on #MachineLearning for #ClinicalResearch are now available online

Marco Grangetto, UniTO, presented on “Foundation Models in #Neuroimaging”, https://www.youtube.com/watch?v=Z2hLXQwKSyg&ab_channel=Sismec

Maurizio Polano, CRO-Aviano IRCCS, gave a lightning talk on “Enhancing #PrecisionMedicine and #ClinicalTrial Methodologies by Machine Learning”, https://www.youtube.com/watch?v=Gkg6AwBWhFc&ab_channel=Sismec

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

https://clinicaltrials.gov/study/NCT06901687?cond=Multiple+Sclerosis

An Open-Label, Parallel-Group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Ocrelizumab in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507313-94-00

A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

https://clinicaltrials.gov/study/NCT06900192?cond=Multiple+Sclerosis

Metabolic Imaging of Neurological Disease

https://clinicaltrials.gov/study/NCT06900244?cond=Multiple+Sclerosis

P3-IMU-838-RMS-02 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514619-88-00